Is thrombolysis of lower extremity acute arterial occlusion cost- effective?

Journal of Surgical Research

Volumn 83, Issue 2, 1999, Pages 106-112

  Patel, Sheela T ^a   Haser, Paul B ^a   Bush Jr , Harry L ^a   Kent, K Craig ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Cost effectiveness; Thrombolysis; Vascular

Indexed keywords

FIBRINOLYTIC AGENT; UROKINASE;

ARTICLE; BLOOD CLOT LYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; HUMAN; LEG AMPUTATION; LEG ISCHEMIA; LEG THROMBOSIS; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MORTALITY; OUTCOMES RESEARCH; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL;

EID: 0033562160     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1999.5575     Document Type: Article

References (21)

1. Weaver F. A., Comerota A. J., Youngblood M., Froehlich J., Hosking J. D., Papanicolaou G. Surgical revascularization versus thrombolysis for nonembolic lower extremity native artery occlusions: Results of a prospective randomized trial. J. Vasc. Surg. 24:1996;513.
2. Ouriel K., Veith F. J., Sasahara A. A. A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. N. Engl. J. Med. 338:1998;1105.
3. Sonnenberg F. A., Beck J. R. Markov models in medical decision making: A practical guide. Med. Decis. Making. 13:1993;322.
4. Goldman L., Gordon D. J., Rifkind B. M., Hulley S. B., Detsky A. S., Goodman D. W., Kinosian B., Weinstein M. C. Cost and health implications of cholesterol lowering. Circulation. 85:1992;1960.
5. Gold M. R., Siegel J. S., Russell L. B., Weinstein M. C. Cost-Effectiveness in Health and Medicine. 1996;Oxford Univ. Press, New York.
6. National Center for Health Statistics, Vital Statistics of the United States, 1988, Washington, DC, U.S. Public Health Service, 1990.
7. Abou-Zamzam A. M. Jr., Lee R. W., Moneta G. L., Taylor L. M. Jr., Porter J. M. Functional outcome after infrainguinal bypass for limb salvage. J. Vasc. Surg. 25:1997;287.
8. Kalman P. G., Johnston K. W. Predictors of long-term patient survival after in situ vein leg bypass. J. Vasc. Surg. 25:1997;899.
9. Dawson I., Keller P. J. A., Brand R., Pesch-Batenburg J., van Bockel J. H. Late outcomes of limb loss after failed infrainguinal bypass. J. Vasc. Surg. 21:1995;613.
10. Luther M. Surgical treatment of chronic critical leg ischemia: A five-year follow-up of survival, mobility, and treatment level. Eur. J. Surg. 164:1998;35.
11. Jansen R. M. G., de Vries S. O., Cullen K. A., Donaldson M. C., Hunink M. G. M. Cost-identification analysis of revascularization procedures on patients with peripheral arterial occlusive disease. J. Vasc. Surg. 28:1998;617.
12. Roddy S. P., O'Donnell T. F., Iafrati M. D., Isaacson L. A., Bailey V. E., Mackey W. C. Reduction of hospital resources utilization in vascular surgery: A four-year experience. J. Vasc. Surg. 27:1998;1066.
13. Gupta S. K., Veith F. J. Inadequacy of diagnosis related group (DRG) reimbursements for limb salvage lower extremity arterial reconstructions. J. Vasc. Surg. 11:1990;348.
14. Vesely T. M., Idso M. C., Audrain J., Windus D. W., Lowell J. A. Thrombolysis versus surgical thrombectomy for the treatment of dialysis graft thrombosis: Pilot study comparing costs. JVIR. 7:1996;507.
15. Hunink M. G. M., Wong J. B., Donaldson M. C., Meyerovitz M. F., de Vries J., Harrington D. P. Revascularization for femoropopliteal disease: A decision and cost-effectiveness analysis. J. Am. Med. Assoc. 274:1995;165.
16. Eckman M. H., Greenfield S., Mackey W. C., Wong J. B., Kaplan S., Sullivan L., Dukes K., Pauker S. G. Foot infections in diabetic patients: Decision and cost-effectiveness analyses. J. Am. Med. Assoc. 273:1995;712.
17. Raviola C. A., Nichter L. S., Baker J. D., Busuttil R. W., Machleder H. I., Moore W. S. Cost of treating advanced leg ischemia: Bypass graft vs primary amputation. Arch. Surg. 123:1988;495.
18. Kuntz K. M., Kent K. C. Is carotid endarterectomy cost-effective? An analysis of symptomatic and asymptomatic patients. Circulation. 94:1996.
19. Ouriel K., Kolassa M., DeWeese J. A., Green R. M. Economic implications of thrombolysis or operation as the initial treatment modality in acute peripheral arterial occlusion. Surgery. 118:1995;810.
20. Bell G. K., Bettman M. A., Wiener T., Lucas C., Krone S., McDaniel M. D. Peripheral vascular disease intervention cost analysis. Circulation. 94:1996.
21. Porter J. M. Thrombolysis for acute arterial occlusion of the legs. N. Engl. J. Med. 338:1998;1148.